Profanna Pyle News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Amaroq Therapeutics, a biotechnology company focussed on developing a new class of therapeutics that target lncRNA in cancer, is progressing.

New yorkUnited statesNew zealandUnited kingdomCold spring harbor laboratoryColumbia universityAnna marie pyleSantaris pharmaDavidl spectorSarah diermeierSherene loiProfdavidl spectorProfanna pyleDuncan mackintoshBoehringer mannheimBreast cancer research foundation